| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/06/2006 | CN1829517A Guanidino-substituted quinazolinone compounds as MC4-R agonists |
| 09/06/2006 | CN1829516A S 2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 09/06/2006 | CN1829511A Use of angiotensin II receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 09/06/2006 | CN1829508A Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 09/06/2006 | CN1829506A Novel coumarin-amide derivatives and its preparation, its drug composition and use |
| 09/06/2006 | CN1829504A Amino acid composition and supplementary liquid containing the same |
| 09/06/2006 | CN1827618A Isoquinoline derivatives and their preparation process and application |
| 09/06/2006 | CN1827603A Novel pyrazole analogs acting on cannabinoid receptors |
| 09/06/2006 | CN1827170A Composition containing dihydropyridin type of calcium antagonists and fibrates medicine |
| 09/06/2006 | CN1827168A Treatment of t cell mediated autoimmune disorders |
| 09/06/2006 | CN1827130A Formulation prepared from effective parts of red sage root and moutan bark, its compound preparation method and medical application |
| 09/06/2006 | CN1827122A Quality control method of heat-clearing toxin-removing cold-treating honeysuckle injection |
| 09/06/2006 | CN1827121A Preparation of safflower and its extract and their medical application in promoting tissue blood vessel regeneration |
| 09/06/2006 | CN1826974A Health seasoning |
| 09/06/2006 | CN1826972A Health-caring product capable of reducing blood sugar |
| 09/06/2006 | CN1826922A Preparation and process for instant soluble tea with fiveleaf gynostemma herb |
| 09/06/2006 | CN1826917A Health drink with milk and snow lotus live body and preparation method |
| 09/06/2006 | CN1273467C Beta-lactam compounds, process for producing the same and serum cholesterol-lowering agents containing the same |
| 09/06/2006 | CN1273466C Quinoline derivatives and quinazoline derivatives having azolyl group |
| 09/06/2006 | CN1273451C Piperidine MCH antagonists and their use in treatment of obesity |
| 09/06/2006 | CN1273450C 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 09/06/2006 | CN1273449C Crystalline forms of atorvastatin |
| 09/06/2006 | CN1273417C Technological method for extracting active principle of dragon's blood by supercritical fluid |
| 09/06/2006 | CN1273191C Method and composition for altering a B cell mediated pathology |
| 09/06/2006 | CN1273187C Zinc-free or low-zinc preparation with improved stability |
| 09/06/2006 | CN1273175C Preparation method of ginseng fruit extractive and its medicinal usage for treating diabetes |
| 09/06/2006 | CN1273152C Capsule for treating diabetes and productive method thereof |
| 09/06/2006 | CN1273135C Pharmaceutical composition of N-methyl-D-aspartate receptor agonist |
| 09/06/2006 | CN1273129C Therapeutic compositions (II) |
| 09/06/2006 | CN1273124C Medicinal composition containing calcium and iron elements |
| 09/06/2006 | CN1273112C Fibrate-statin combinations with food-reducing and -fasting function |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7102007 Dihydroindole and tetrahydroquinoline derivatives |
| 09/05/2006 | US7102000 Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
| 09/05/2006 | US7101977 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 09/05/2006 | US7101960 Process for removing bile salts from a patient and alkylated compositions therefor |
| 09/05/2006 | US7101910 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 09/05/2006 | US7101907 Topical administration of statins for treatment of bone disorders |
| 09/05/2006 | US7101905 Pharmaceutically active compounds and methods of use |
| 09/05/2006 | US7101899 N-[4-[2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide; adenosine A3 receptor antagonistic activity |
| 09/05/2006 | US7101889 Lipase inhibiting composition |
| 09/05/2006 | US7101882 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 09/05/2006 | US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents |
| 09/05/2006 | US7101871 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/05/2006 | US7101865 24-sulfoximine vitamin D3 compounds |
| 09/05/2006 | US7101856 Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 09/05/2006 | US7101851 IgE receptor antagonists |
| 09/05/2006 | US7101843 Amino acid sequence of His-Val-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Glu-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Ile-Lys-Gly-Arg-Gly-OH; obesity, stroke, myocardial infarction, irritable bowel syndrome, non-insulin dependent diabetes |
| 09/05/2006 | US7101577 Extract of plant Dendrobii caulis and preparing process thereof |
| 09/05/2006 | US7101574 Pharmaceutical composition containing fenofibrate and the preparation method |
| 09/05/2006 | US7101559 Immunomodulatory protein and useful embodiments thereof |
| 09/05/2006 | US7101554 Picornaviruses, vaccines and diagnostic kits |
| 09/05/2006 | US7101550 Agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response |
| 09/05/2006 | US7101548 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 09/05/2006 | US7101546 Encapsulating a cell culture of propagating pancreatic cells; inserting the encapsulated cells into the mammal permitting the cells to mature to insulin secreting cells |
| 09/05/2006 | US7101544 Kluyveromyces marxianus yeast in milk or fruit juice |
| 09/05/2006 | CA2393640C Pyrrolo[2,3-d]pyrimidine compounds |
| 08/31/2006 | WO2006091592A1 Naphthalene derivatives as modulators of the glucocorticoid receptor |
| 08/31/2006 | WO2006091381A1 Humanized anti-ghrelin antibodies |
| 08/31/2006 | WO2006090932A1 Surrogate marker for sulfonamide compound |
| 08/31/2006 | WO2006090927A1 Orexigenic action of sulfonamide compound |
| 08/31/2006 | WO2006090921A1 Inhibitory effect of sulfonamide compound on lymphocyte activation |
| 08/31/2006 | WO2006090920A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR ACTIVATING RECEPTOR δ |
| 08/31/2006 | WO2006090915A1 Pyridyl acetic acid compounds |
| 08/31/2006 | WO2006090768A1 Process for production of optically active ppar-activating compound and intermediate of the same |
| 08/31/2006 | WO2006090767A1 PROMOTER OF REGENERATION OF PANCREATIC β CELL, AND PROMOTER OF INSULIN PRODUCTION IN PANCREATIC β CELL |
| 08/31/2006 | WO2006090756A1 Novel preventive or remedy for lipid metabolism disorder, obesity and diabetes and use therefor |
| 08/31/2006 | WO2006090698A1 Kinase inhibitor and use thereof |
| 08/31/2006 | WO2006090616A1 Fat cell differentiation regulator |
| 08/31/2006 | WO2006090544A1 Chewable tablet containing collagen peptide and process for producing the same |
| 08/31/2006 | WO2006090250A1 Substituted 1,1,1-trifluoro-3-[(benzyl)-(pyrimidin-2-yl)-amino]-prop an-2-ol compounds |
| 08/31/2006 | WO2006090244A1 New adamantane derivatives as dipeptidyl, peptidase iv inhibitors, processes for their preparation, and pharmaceutical compositions containing them |
| 08/31/2006 | WO2006090150A1 Pharmaceutical composition comprising amorphous rosiglitazone |
| 08/31/2006 | WO2006089987A1 Use of leptin for the prevention of excess body weight and composition containing leptin |
| 08/31/2006 | WO2006072393A3 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 08/31/2006 | US20060194879 Pharmaceutically useful salts of carboxylic acid derivates |
| 08/31/2006 | US20060194872 Diamine derivative, production process therefor and antioxidant |
| 08/31/2006 | US20060194871 Heterocyclic mchr1 antagoists |
| 08/31/2006 | US20060194868 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and /or congestive heart failure |
| 08/31/2006 | US20060194864 Indole derivatives |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194862 respiratory, urinary and gastrointestinal systems disorders; 2-cyclopentyl-2-hydroxy-N-[(3S)-1-benzyl-pyrrolidin-3-yl]-2-phenyl acetamide; side effects reduction; compounds exhibit significant potency |
| 08/31/2006 | US20060194857 Anti-diabetic activity, improves insulin resistance and control the blood glucose level more safely, simulates activity of peroxisome proliferator-activated receptor; (1-{(2E)-3-[3-(Bromomethyl)phenyl]prop-2-en-1-yl}-1H-pyrrol-2-yl)(4-methyl-phenyl)methanone |
| 08/31/2006 | US20060194854 New 2-substituted - 1,3-thiazole compounds |
| 08/31/2006 | US20060194848 Substituted amine derivatives and methods of use |
| 08/31/2006 | US20060194836 Novel compounds having 4-pyridylalkylthio group as substituent |
| 08/31/2006 | US20060194834 Serotonin receptor antagonist; psychological disorders; Alzheimer's disease |
| 08/31/2006 | US20060194828 Vitamin comprising pyroloquinoline quinone and use thereof |
| 08/31/2006 | US20060194822 Treatment for renal fibrosis |
| 08/31/2006 | US20060194818 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194793 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194792 1-Cyclic carbonyl-4-(4-quinoline-)-1,4-diazepine or 1-cyclic carbonyl-4-[4-(1H-quinolin-2-{thio}one)-1,4-diazepinone derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 08/31/2006 | US20060194780 N-Azacycloalkylcarbonyl-substituted bicyclic piperidines, e.g., N-tert-butyl)-8-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]carbonyl}-3-cyclohexyl-8-azabicyclo[3.2.1]octane-3-carboxamide; useful for treating obesity, diabetes, and sexual dysfunction |
| 08/31/2006 | US20060194778 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 08/31/2006 | US20060194772 Triamide-substituted heterobicyclic compounds |
| 08/31/2006 | US20060194745 Compounds and methods for inhibiting selectin-mediated function |
| 08/31/2006 | US20060194735 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 08/31/2006 | US20060194720 Human glucagon-like peptide-1 (GLP-1) derivatives absorbed highly via a mucous membrane in the oral cavity, lung, nose or intestines; for therapy of non-insulin dependent diabetes muellitus, insulin dependent diabetes mellitus and/or obesity |